Your follicles are waiting
Beyond Ozempic: How Indian startups are building around GLP-1 drugs Even though India prohibits direct-to-consumer marketing of prescription drugs, regulators are watching out for messaging to induce misuse The first time Tushar Vashisht, co-founder and CEO of health and fitness app Healthify, tried taking a semaglutide-class weight-loss drug in 2024, it was solely to experience what it does to his metabolism
This is easy to overlook but genuinely matters for maintaining the medication's stability over those 56 days
Track your weight, measurements, appetite changes, and side effects
Conversely, ingredient suppliers whose volumes are more linearly linked to ingredient growth, could be adversely affected by reduced portion sizes, as their sales depend more heavily on the quantity of ingredients sold
This is the opposite of the antagonistic relationship seen with ibuprofen